ONC
NASDAQ
$310.58
BeiGene Ltd (ONC)
BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company is headquartered in Camana Bay, the Cayman Islands.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $414.83 (+33.57%)
Market Cap
$36B
Revenue 5Y CAGR
+46.08%
Forward P/E
47.39
P/E Ratio
69.54
Price Chart
Valuation
Market Cap$36B
P/E69.54
Forward P/E47.39
P/S5.63
P/B6.68
Profitability
Total Revenue (TTM)$5.74B
Gross Profit (TTM)$5.07B
EBITDA$902M
Profit Margin15%
Operating Margin16.5%
EPS$4.48
Financial Health
Debt-to-Equity24.1%
Free Cash Flow Yield2.35%
Growth & Risk
Revenue 5Y CAGR+46.08%
Beta (5Y)0.54
Sharpe Ratio0.27